Gladstone Institutional Advisory’s NEOS Enhanced Income 1-3 Month T-Bill ETF CSHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.31M Sell
66,484
-11,097
-14% -$553K 0.1% 203
2026
Q1
$3.86M Sell
77,581
-8,419
-10% -$418K 0.14% 162
2025
Q4
$4.28M Buy
86,000
+37,973
+79% +$1.89M 0.16% 140
2025
Q3
$2.39M Sell
48,027
-12,192
-20% -$607K 0.09% 217
2025
Q2
$2.99M Buy
60,219
+3,210
+6% +$159K 0.12% 177
2025
Q1
$2.83M Sell
57,009
-31,296
-35% -$1.56M 0.13% 170
2024
Q4
$4.4M Sell
88,305
-4,367
-5% -$218K 0.2% 113
2024
Q3
$4.62M Buy
92,672
+65,640
+243% +$3.27M 0.23% 108
2024
Q2
$1.35M Buy
+27,032
New +$1.35M 0.07% 273

Other funds holding CSHI

Gladstone Institutional Advisory's CSHI Position: Q2 2026 in Review

Gladstone Institutional Advisory reduced its NEOS Enhanced Income 1-3 Month T-Bill ETF (CSHI) stake by 14% in Q2 2026, selling an estimated $553K and leaving 66,484 shares worth $3.31M. The position accounts for 0.1% of the portfolio, ranked #203.

Gladstone Institutional Advisory first reported a position in CSHI in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.62M in Q3 2024. 127 funds tracked by Wall St. Rank hold CSHI as of Q2 2026.

  • Gladstone Institutional Advisory held 66,484 shares of NEOS Enhanced Income 1-3 Month T-Bill ETF worth $3.31M as of Q2 2026.
  • Gladstone Institutional Advisory sold 11,097 NEOS Enhanced Income 1-3 Month T-Bill ETF shares in Q2 2026, an estimated $553K.
  • NEOS Enhanced Income 1-3 Month T-Bill ETF made up 0.1% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #203 holding.
  • Gladstone Institutional Advisory first reported a position in NEOS Enhanced Income 1-3 Month T-Bill ETF in Q2 2024 and has held it in 9 quarters since.
  • Gladstone Institutional Advisory's NEOS Enhanced Income 1-3 Month T-Bill ETF position peaked at $4.62M in Q3 2024.
  • 127 funds tracked by Wall St. Rank held NEOS Enhanced Income 1-3 Month T-Bill ETF as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.